What is CorMedix's debt-to-equity?

CorMedix (CRMD) reported debt-to-equity of 0× in Q4 2025.

How has CorMedix's debt-to-equity changed year-over-year?

CorMedix's debt-to-equity increased by 73.8% year-over-year, from 0× to 0×.

What is the long-term trend for CorMedix's debt-to-equity?

Over 5 years (2020 to 2025), CorMedix's debt-to-equity has grown at a -14.6% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

CorMedix CRMD Debt-to-equity

Debt-to-equity at other companies

PfizerPFE

0.7×0.0×

Merck & Co.MRK

1.1×+0.3×

Merit Medical SystemsMMSI

0.5×-0.1×

ITG

Integer HoldingsITGR

0.8×0.0×

IAR

Integra LifeSciencesIART

1.9×+0.6×

MiMedx GroupMDXG

0.1×0.0×

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Current ratio3×-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

total debt/total stockholders equity=0×

Based on the most recent quarter.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's debt-to-equity?: CorMedix (CRMD) reported debt-to-equity of 0× in Q4 2025.
How has CorMedix's debt-to-equity changed year-over-year?: CorMedix's debt-to-equity increased by 73.8% year-over-year, from 0× to 0×.
What is the long-term trend for CorMedix's debt-to-equity?: Over 5 years (2020 to 2025), CorMedix's debt-to-equity has grown at a -14.6% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.